SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 85 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2013. The put-call ratio across all filers is 0.34 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $30,000 | +7.1% | 17,513 | +41.2% | 0.00% | – |
| Q2 2015 | $28,000 | -34.9% | 12,405 | -23.2% | 0.00% | – |
| Q4 2014 | $43,000 | +4.9% | 16,148 | +18.0% | 0.00% | – |
| Q3 2014 | $41,000 | -63.4% | 13,685 | -47.2% | 0.00% | – |
| Q1 2014 | $112,000 | +72.3% | 25,932 | +108.5% | 0.00% | – |
| Q4 2013 | $65,000 | -3.0% | 12,435 | +18.0% | 0.00% | – |
| Q3 2013 | $67,000 | +28.8% | 10,542 | +1.6% | 0.00% | – |
| Q2 2013 | $52,000 | – | 10,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|